1. China Stocks

  2. •

    Non-energy minerals

  3. •

    Forest products
China Health Technology Group Holding Company Limited

China Health Technology Group Holding Company Limited

HHKEX:1069
0.25
HKD
+0.00
(+1.64%)
42.20MMarket Cap
China Health Technology Group Holding Company Limited
HKEX:1069
(Hong Kong Exchange)

Recent

price

0.25

P/E

ratio

- -

div

yld

- -

ROIC.AI

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2022
2023
2024
2025
TTM
CNY
57.35
79.44
72.59
36.31
11
8.41
2.65
3.76
17
5.94
3.68
0.51
0.52
4.51
0.6
0.92
- -
Revenue per Share
6.17
9.07
0.16
-7.87
-7.47
-28.31
-15.64
-11.08
-1.54
-7.55
-26.13
-12.16
-1.45
-0.83
2.52
0.23
- -
Basic EPS, GAAP
3.83
5.16
-0.33
1.31
-11.3
-15.17
-7.07
-10.75
1.82
-0.64
-0.77
-0.43
-0.04
1.7
0.36
0.34
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
23.4
31.82
31.98
29.02
29.98
39.33
46.23
61.62
63.68
46.1
19.36
9.37
-23.54
-24.31
0.15
0.46
0.47
Book Value per Share
23.4
31.82
31.98
29.02
29.98
39.33
46.23
33.53
51.3
42.39
19.36
9.37
-23.54
-24.31
0.15
0.46
0.47
Tangible Book Value per Share
3
3
3
3
3
3
4
5
5
9
13
13
13
13
79
98
110
Basic Weighted Avg Shares
146
202
185
92
29
27
10
18
86
51
48
7
7
59
48
90
- -
Sales/Revenue/Turnover
10.92
13.28
1.04
-8.03
-35.48
-141.3
-334.96
-108.58
-2.63
-23.54
13.92
-634.76
-173.28
-14.32
-44.1
-9.23
- -
Operating Margin (%)
1
1
1
1
1
1
3
11
29
21
3
- -
2
3
5
5
- -
Depreciation Expense
16
23
- -
-20
-20
-90
-60
-52
-8
-65
-340
-158
-19
-11
200
23
- -
Net Income, GAAP
- -
13.57
73.15
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1.37
- -
Effective Tax Rate (%)
10.75
11.42
0.22
-21.68
-67.87
-336.56
-590.74
-294.57
-9.04
-127.05
-710.66
-2,377.02
-279.75
-18.39
420.14
25.17
- -
Profit Margin (%)
44
57
59
60
71
-10
42
16
88
85
-159
-234
-335
-420
-2
17
10
Working Capital
- -
- -
- -
13
236
103
124
175
354
198
159
124
52
14
116
116
114
LT Debt
61
81
81
74
82
152
199
312
386
601
252
122
-307
-317
13
47
57
Total Equity
31.95
31.41
0.59
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
231.88
17.32
- -
Return on Invested Capital (%)
31.95
31.75
0.62
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
236.13
17.73
- -
Return on Capital (%)
33.41
32.85
0.51
-25.81
-25.23
-81.42
-36.06
-20.82
-2.22
-13.22
-79.85
-84.67
- -
- -
- -
76.11
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Jun'25
Dec'26
ST Debt
2
1
- -
LT Borrowings
113
116
114
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
102
102
122
Market Capitalization
28
34
38

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Jun'25
Dec'26
Total Current Assets
53
60
40
Cash, Cash Equivalents & STI
3
4
3
Accounts Receivable, Net
21
34
24
Inventories
4
1
6
Total Current Liabilities
53
43
30
Payables & Accruals
- -
- -
- -
ST Debt
2
1
- -
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-13.38%
-48.64%
260.41%
Free Cash Flow
-510.09%
-989.04%
17.28%
Net Income, GAAP
-119.14%
-445%
-88.65%
Sales/Revenue/Turnover
110.23%
150.99%
89.5%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
48
2025
- -
- -
90
2026
- -
- -
- -

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
2.52
2025
- -
- -
0.23
2026
- -
- -
- -

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Similar Companies
PT Barito Pacific Tbk (IDX:BRPT)
Premier Polyfilm Limited (NSE:PREMIERPOL)
CL Workshop Group Limited (NASDAQ:NWGL)
Stylam Industries Limited (NSE:STYLAMIND)
FORMET METAL VE CAM SANAYI A.S. (BIST:FORMT)
HHRG BERHAD (MYX:HHRG)
Business
China Health Technology Group Holding Company Limited operates as an investment holding enterprise, deeply involved in the management of agricultural and forestry resources. The company's activities span from the cultivation, harvesting, and sale of timber, to dedicated businesses in ginseng, horny goat weed, and an expanding portfolio of health products, with a strategic emphasis on "Big Health" and "Rural Revitalization" in mainland China. Established on October 8, 2009, the firm's principal office is situated in Hong Kong.